Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Modified

The PHUSE Working Groups, which are led by volunteers from major stakeholders, have been developing innovative solutions that address unmet computational science needs. Here, we will look to share the latest information around the PHUSE Working Groups, from workshops to White Papers, project news and Industry views.Image Removed
Working Groups End of Year blogOver the course of the year, the PHUSE Working Groups have published 28 deliverables and concluded 12 projects. Read our latest blog to find out all they have achieved in 2020.Working Groups Latest ReportThis Report provides a detailed overview of the projects progress to date.

Image Added


PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global.


Image Added


Open Source – Regulatory Acceptance of Open-Source Submissions

Registration for the Open Source Open Forum is open!

The Open Source Technology in Clinical Data Analysis (OSTCDA) project is hosting their fourth Open Forum: Regulatory Acceptance of Open-Source Submissions, they will be addressing the following questions:

  • Will the FDA accept data and analyses generated with solutions developed and available as open source?
  • Will other regulatory agencies accept data and analyses generated with solutions developed and available as open source?

Come and be a part of our next virtual Open Forum on 12 July at 15:00(BST) 10:00(EDT).

Status
colourBlue
titleRegister Here


Understanding the Complete Journey of RWD, from Data Source to Final Analysis 

Registration for the RWE Community Forum is open!

The Real World Evidence Working Group is hosting their third Community Forum of the year! This forum will looking at 'Understanding the Complete Journey of RWD, from Data Source to Final Analysis'. As an industry, we are continuously accumulating experiences in working with real-world data (RWD) sources that collectively yield benefits – from enhanced generalisability of findings to facilitating faster approval timelines. However, these efforts are not without their challenges.

Come and be a part of our next virtual Community Forum on 11 July at 14:00(BST) 9:00(EDT).

Status
colourBlue
titleRegister Here


Image Added


The Dataset-JSON as Alternative Transport Format for Regulatory Submissions project within the Optimizing the Use of Data Standards Working Group, has published a new white paper. A pilot was executed to test the feasibility of using Dataset-JSON as a transport format for study data submitted with regulatory applications. The goal was to demonstrate that Dataset-JSON can serve as a transport file for study data without loss of data and no significant impact to business operations.  

CDISC Dataset-JSON is a modern dataset format designed for data exchange. Many software applications already import and export JSON and in the longer term more significant benefits will emerge as the constraints imposed by XPT are removed. 

Overall, the findings were consistent across industry and the FDA supporting the use of Dataset-JSON as an alternative transport format for XPT v5.  There were several key findings from the pilot and the solutions to these will be implemented in Dataset-JSON v1.1 (due end of 2024). 

PHUSE and CDISC will continue to collaborate with the FDA/PMDA to discuss next steps for regulatory support. FDA/CDER/CBER testing strongly suggests that analytical tools used for regulatory review are updated to take advantage of the metadata and flexibility provided by the Dataset-JSON format. 


The SEND Industry Feedback Surveyproject within the Nonclinical Topics Working Group, has published the 2024 SEND Survey Results. The survey was presented at the PHUSE/FDA Computational Science Symposium (CSS) 2024 and covered topics such as Manual Edits, Implementing SEND, Harmonisation and Next Steps.


The Adverse Event Collection Recommendations project within the Safety Analytics Working Group, has published a new white paper The Adverse Event Collection Recommendations. This white paper provides recommendations for adverse event (AE) collection and associated instructions for Phase II to III clinical trials, building on standardisation efforts by Clinical Data Interchange Standards Consortium (CDISC) and PHUSE. The primary intent is to reduce the variation in AE collection and instructions to improve the site experience and the quality of the data.


The Quality and Reusability of Real World Data project within the Real World Evidence Working Group, has published two new Blogs! The 'Understanding the Data Quality Issues in Real-World Data Through Real-World Examples', blog takes a closer look at the experiences shared within the dedicated Working Group in exploring the types of data quality hurdles encountered when using Real-World Data (RWD).The 'Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products' blog explores the use of Real-World Evidence (RWE) as a powerful tool for informing regulatory decisions and advancing medical innovation.


The Educate the General Population on Data Privacy and Data Sharing project, within the Data Transparency Working Group has published video 2 of their series. The 'What Will I Receive and When Will I Receive It?The video covers topics such as the concept of consent to participate in a clinical trial, an overview of trial design and treatment procedures to develop a strong foundational understanding of clinical trials. To view the full series of videos created by this team, visit the PHUSE website


Image Added


The Enhanced Risk-based Quality Management (RBQM) Approaches for First-in-Human and/or Small Clinical Trialsa new project within the Risk Based Quality ManagementWorking Group, is now calling for volunteers. This project aims to to discuss and focus on a robust strategy/process and best practices for:

  • Identifying critical items
  • Risk Based data review approaches
  • Risk Based Monitoring approach strategy (tSDV/tSDR)
  • Usage of analytical tools and methods for data review & central monitoring, including limitations on (statistical) methodologies
  • Identification of thresholds or equivalent on limited patient data
  • Targeted medical review
  • Strategy to adequately anticipate on highly dynamic data
  • Establish links with the other work streams on FIH/small studies focus

If you would like to volunteer or learn more about this project, email workinggroups@phuse.global. Closing date: 5 July

Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global


Image Added


Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. 


Image Added

Projects Calling for Participants 

The Emerging Trends & Technologies Working Group is actively seeking a new Project Co-Lead to work alongside Geoff Low for the FHIR team initiative. Here you will find an overview of the project scope together with an outline of their deliverables. The team are currently reviewing these and adapting their timelines accordingly, so now would be a great time to get involved.

Expectations:

  • Commit to attend, actively lead and contribute towards the Project
  • Attend and lead breakout sessions (where necessary) at the annual PHUSE Computational Science Symposium (CSS)   
  • Support in the production of agenda’s, minutes and chasing of outstanding actions
  • Provide regular project updates at the monthly Working Group Leads meeting

We ask that all applicants interested in this role, provide a brief summary of how you feel you can contribute to driving this project forward. All applications are to be submitted to workinggroups@phuse.global, the closing date for applications is Friday 19th March

The new Best Practices in Data Standards Implementation Governance project which falls under the Optimising the Use of Data Standards Working Group is calling for volunteers! Click here for more information on the scope of the project, email workinggroups@phuse.global to get involved.   

The FDA Oncology Safety Data Standards project aims to obtain broad industry and CRO feedback on the current publicly available OCE/OOD standard safety data request and assist with the development of resources to assist sponsors with implementation of these data specifications. This project is calling for volunteers, email workinggroups@phuse.global for more information.  

The Synthetic Data Project will be hosting five 90-min training sessions on a monthly basis until July. Hosted by Replica Analytics, the training sessions will review different techniques and explore different use cases relevant to the Life Sciences industry. During the time leading to July, the project team will elaborate on the first deliverable to focus on following the end of the training period. If you want to sign up to the Data Synthesis project and gain access to the PODR, please contact workinggroups@phuse.global. You can already sign up to the first session on March 4th on eventbrite. 

Project Idea?


Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must

address

address problems of significant relevance to computational science related to drug,

biologic

biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here

for template and submission.Webinars Events 

Image Removed

Have you attended a PHUSE Webinar Wednesday?

They run throughout the year around the last Wednesday of every month and include presentations of hot topics in the industry and PHUSE.
Click here to register and view previous presentations. 

Image Removed

Our PHUSE events are different in both nature and set-up. PHUSE events started back in 2004 with the inaugural PHUSE conference in Heidelberg. Since then PHUSE has been organising events all over the globe. With that, we strive to meet the needs of our global membership to share, advance and connect. All our events are aimed at different audiences. Click the banner above to see upcoming events. 

Webinars Events 

Image Removed

Have you attended a PHUSE Webinar Wednesday?

They run throughout the year around the last Wednesday of every month and include presentations of hot topics in the industry and PHUSE.
Click here to register and view previous presentations. 

Image Removed

Our PHUSE events are different in both nature and set-up. PHUSE events started back in 2004 with the inaugural PHUSE conference in Heidelberg. Since then PHUSE has been organising events all over the globe. With that, we strive to meet the needs of our global membership to share, advance and connect. All our events are aimed at different audiences. Click the banner above to see upcoming events

to submit